No abstract available
MeSH terms
-
Adolescent
-
Age Factors
-
Albuterol / analogs & derivatives
-
Albuterol / therapeutic use
-
Androstadienes / therapeutic use
-
Anticonvulsants / therapeutic use
-
Asthma / drug therapy
-
Asthma / prevention & control
-
Atovaquone
-
Attention Deficit Disorder with Hyperactivity / drug therapy
-
Beclomethasone / therapeutic use
-
Carbamazepine / analogs & derivatives*
-
Carbamazepine / therapeutic use
-
Child
-
Delayed-Action Preparations
-
Diabetes Mellitus, Type 1 / drug therapy
-
Drug Approval / statistics & numerical data*
-
Drug Combinations
-
Drug Delivery Systems
-
Drug Therapy / standards*
-
Epilepsies, Partial / drug therapy
-
Fluticasone-Salmeterol Drug Combination
-
HIV Protease Inhibitors / therapeutic use
-
Humans
-
Insulin / analogs & derivatives*
-
Insulin / therapeutic use
-
Insulin Glargine
-
Insulin, Long-Acting
-
Lopinavir
-
Methylphenidate / therapeutic use
-
Naphthoquinones / therapeutic use
-
Nebulizers and Vaporizers
-
Oxcarbazepine
-
Pediatrics / methods*
-
Proguanil / therapeutic use
-
Pyrimidinones / therapeutic use
-
Ritonavir / therapeutic use
-
United States
Substances
-
Androstadienes
-
Anticonvulsants
-
Delayed-Action Preparations
-
Drug Combinations
-
Fluticasone-Salmeterol Drug Combination
-
HIV Protease Inhibitors
-
Insulin
-
Insulin, Long-Acting
-
Naphthoquinones
-
Pyrimidinones
-
atovaquone, proguanil drug combination
-
Methylphenidate
-
Lopinavir
-
Insulin Glargine
-
Carbamazepine
-
Beclomethasone
-
Ritonavir
-
Albuterol
-
Proguanil
-
Oxcarbazepine
-
Atovaquone